Ethris has entered a strategic partnership with Thermo Fisher Scientific for providing completely integrated mRNA solution.

This trial evaluated the safety and efficacy of the combination of Regeneron’s Lynozyfic (linvoseltamab), a B-cell maturation antigenxCD3 bispecific T-cell engager (BiTE), and Amgen’s Kyprolis ...